NEW YORK (GenomeWeb News) – BioReference Laboratories said today that it will acquire certain assets of Edge Biosystems, a reagents and sequencing services company.

As part of the agreement, BioReference's subsidiary GeneDx will acquire EdgeBio's genetic sequencing service business, Edge BioServ, which provides sequencing services in a CLIA certified laboratory. EdgeBio will retain its products business, a company official told GenomeWeb Daily News.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.